Loading...
•
Sep 30, 2023
Artivion Q3 2023 Earnings Report
Reported an increase in revenue and a decrease in net loss compared to the same quarter last year.
Key Takeaways
Artivion reported a 14% increase in revenue to $87.9 million in Q3 2023. Net loss decreased to ($9.8) million, and non-GAAP net income was $749,000. The company is raising its revenue guidance for the full year 2023.
Revenue increased by 14% on a GAAP basis and 12% on a non-GAAP constant currency basis.
Net loss was ($9.8) million, or ($0.24) per share; non-GAAP net income was $749,000, or $0.02 per share.
Aortic stent graft revenues increased 30% on a GAAP basis and 22% on a non-GAAP constant currency basis.
On-X revenues increased 14% on a GAAP basis and 13% on a non-GAAP constant currency basis.
Forward Guidance
Artivion is raising its revenue guidance range and now expects to achieve constant currency revenue growth of between 11% and 12% for the full year 2023 compared to 2022. The Company expects revenues to be in a range of $349.0 million and $351.0 million. Additionally, Artivion continues to expect non-GAAP adjusted EBITDA to increase by more than 25% in 2023 compared to 2022, resulting in non-GAAP adjusted EBITDA in excess of $52.0 million for 2023.
Positive Outlook
- Expects to achieve constant currency revenue growth of between 11% and 12% for the full year 2023 compared to 2022.
- Revenues to be in a range of $349.0 million and $351.0 million.
- Non-GAAP adjusted EBITDA to increase by more than 25% in 2023 compared to 2022.
- Non-GAAP adjusted EBITDA in excess of $52.0 million for 2023.
- Remain on track to achieve or exceed revenue and adjusted EBITDA growth targets for this year.
Challenges Ahead
- Financial performance for 2023 and future periods is subject to risks.
- Benefits anticipated from the Ascyrus Medical LLC transaction and Endospan agreements may not be achieved at all or at the levels originally anticipated.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...